When: Wednesday, 26 July 2023
Time: 7 pm (AEST)
However, you can watch the recording in the Medihuanna Community.
Join A/Prof Judith Lacey in an exclusive webinar presented by Medihuanna, focusing on 'The Role of Medicinal Cannabis in the Treatment of Patients with Glioblastoma Multiforme - Current Research and Evidence'.
A/Prof Judith Lacey, MBBS, FRACGP, FAChPM (RACP). She holds the position of Head of Supportive Care and Integrative Oncology at Chris O’Brien Lifehouse Comprehensive Cancer Centre in NSW, Australia. Additionally, A/Prof Lacey serves as an Adjunct Associate Professor at the NICM Health Research Institute, Western Sydney University, and as a Senior Clinical Lecturer at the School of Medicine, University of Sydney.
Recognised for her work in integrative oncology, A/Prof Lacey is the National Chair of the Integrative Oncology Group at the Clinical Oncology Association of Australia (COSA). She is also a board member and co-chair of the Clinical Practice Group at the Society for Integrative Oncology (SIO), and serves as an Australian ambassador to SIO. A/Prof Lacey's dedication to her field is further reflected in her membership with the Multinational Association of Supportive Care in Cancer (MASCC).
A/Prof Lacey's primary interest lies in the development and integration of supportive care interventions, including complementary therapies and integrative medicine. Her mission is to ensure people living with cancer maintain the highest quality of life possible, regardless of prognosis or stage of disease. Her holistic approach to patient care involves collaboration with other practitioners to maximize patient wellbeing.
Her research activities span across integrative oncology, medicinal cannabis, and supportive care service development. A/Prof Lacey holds key leadership positions in these fields, contributing to research, teaching, and service development at local, national, and international levels.
In this engaging webinar, A/Prof Judith Lacey, Head of Supportive Care and Integrative Oncology at Chris O’Brien Lifehouse, will delve into the role of medicinal cannabis in the treatment of patients with Glioblastoma Multiforme (GBM), a highly malignant brain cancer with poor prognosis.
Drawing from her extensive expertise and current research, she will discuss the results of a phase II randomized trial and shed light on current and future clinical trials. A/Prof Lacey will offer insights on how best to manage patients with high-grade gliomas using medicinal cannabis, and provide a glimpse into preliminary survivorship data. This is an excellent opportunity for medical professionals to understand the emerging role of medicinal cannabis in oncology, particularly for patients with GBM.
This webinar will be valuable for medical professionals, clinical researchers, and healthcare providers interested in learning more about the use of medicinal cannabis in the oncology setting, particularly in the context of treating patients with Glioblastoma Multiforme.
Medihuanna is a CPD approved education provider, and this activity has been approved by the RACGP (Activity ID: 555572). Upon completing this activity, you will be eligible to claim CPD hours. The activity will include the following CPD allocation which will be uploaded to the RACGP dashboard.
Educational Activity: 1 hour